Additionally, in a KRAS mutant CRC mouse model, suppression of the CXCL3-CXCR2 axis impaired MDSC infiltration, increase of adaptive immunity, and an unexpected efficacy of anti-PD-1 treatment [178]. This evidence concerns the gene PDCD1 and colorectal carcinoma.